Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Roblox
RBLX
|
+$557M |
| 2 |
JPMorgan Chase
JPM
|
+$497M |
| 3 |
Amazon
AMZN
|
+$492M |
| 4 |
AT&T
T
|
+$448M |
| 5 |
Coinbase
COIN
|
+$338M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Advanced Micro Devices
AMD
|
+$706M |
| 3 |
Qualcomm
QCOM
|
+$580M |
| 4 |
Adobe
ADBE
|
+$542M |
| 5 |
Johnson & Johnson
JNJ
|
+$455M |
Sector Composition
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.76% |
| 3 | Consumer Staples | 10.28% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
UGI
UGI
$7.06B
| $1.63M | ﹤0.01% |
35,400
-163,653
| -82% | -$7.51M |
|
2302
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$483M
| $1.62M | ﹤0.01% |
+23,900
| New | +$1.62M |
|
2303
First US Bancshares
FUSB
$73.1M
| $1.62M | ﹤0.01% |
153,476
-9,645
| -6% | -$102K |
|
2304
Generation Bio
GBIO
$38.9M
| $1.62M | ﹤0.01% |
+22,890
| New | +$1.62M |
|
|
CSW
2305
CSW Industrials, Inc.
CSW
$4.14B
| $1.62M | ﹤0.01% |
13,400
+4,900
| +58% | +$592K |
|
2306
Gyre Therapeutics
GYRE
$685M
| $1.62M | ﹤0.01% |
236,254
+230,949
| +4,353% | +$1.58M |
|
2307
New Jersey Resources
NJR
$4.66B
| $1.62M | ﹤0.01% |
39,400
-100
| -0.3% | -$4.11K |
|
2308
Hexcel
HXL
$4.94B
| $1.62M | ﹤0.01% |
+31,200
| New | +$1.62M |
|
|
MLVF
2309
DELISTED
Malvern Bancorp, Inc.
MLVF
| $1.62M | ﹤0.01% |
103,125
-3,139
| -3% | -$49.2K |
|
|
GVP
2310
DELISTED
GSE Systems, Inc.
GVP
| $1.62M | ﹤0.01% |
94,426
-4,838
| -5% | -$82.7K |
|
2311
Barnwell Industries
BRN
$11.8M
| $1.61M | ﹤0.01% |
554,336
+122,168
| +28% | +$355K |
|
2312
Hippo Holdings
HIPO
$926M
| $1.61M | ﹤0.01% |
+22,788
| New | +$1.61M |
|
|
RDUS
2313
DELISTED
Radius Recycling
RDUS
| $1.61M | ﹤0.01% |
30,996
+23,400
| +308% | +$1.21M |
|
2314
a.k.a. Brands
AKA
$111M
| $1.61M | ﹤0.01% |
+14,475
| New | +$1.61M |
|
2315
Alico
ALCO
$257M
| $1.61M | ﹤0.01% |
43,405
-17,991
| -29% | -$666K |
|
2316
Dimensional US Core Equity Market ETF
DFAU
$9.28B
| $1.61M | ﹤0.01% |
48,700
+17,000
| +54% | +$561K |
|
|
ADAP
2317
Adaptimmune Therapeutics
ADAP
$21.4M
| $1.6M | ﹤0.01% |
+427,687
| New | +$1.6M |
|
2318
Mitek Systems
MITK
$452M
| $1.6M | ﹤0.01% |
90,307
-62,701
| -41% | -$1.11M |
|
|
PFIE
2319
DELISTED
Profire Energy, Inc
PFIE
| $1.6M | ﹤0.01% |
1,512,295
+57,200
| +4% | +$60.6K |
|
2320
SPDR Dow Jones REIT ETF
RWR
$1.85B
| $1.6M | ﹤0.01% |
+13,100
| New | +$1.6M |
|
2321
American Well
AMWL
$105M
| $1.6M | ﹤0.01% |
+13,245
| New | +$1.6M |
|
2322
Stride
LRN
$6.04B
| $1.6M | ﹤0.01% |
48,000
-27,300
| -36% | -$910K |
|
2323
Y-mAbs Therapeutics
YMAB
| $1.6M | ﹤0.01% |
+98,600
| New | +$1.6M |
|
|
THRN
2324
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $1.6M | ﹤0.01% |
+257,000
| New | +$1.6M |
|
2325
Champions Oncology
CSBR
$87.6M
| $1.6M | ﹤0.01% |
190,746
-30,400
| -14% | -$254K |
|